Thought-provoking, worldwide issues will be deconstructed by acclaimed panelists representing multiple stakeholders from around the world in this growing ecosystem of life sciences. DIAmonds represent rare opportunities to listen to open conversations on controversial topics such as owning health data, innovation in global health, and international regulatory collaboration.
-
European Regulatory Townhall: Evolving the European Framework to attract Research and Development – Paving the Way for Innovative MedicinesSession Chair:
Anthony Humphreys, Head of the Regulatory Science and Innovation Task Force, European Medicines Agency
-
HTA Townhall: Regulation & Implementation. Access and Affordability
Session Chair:
Niklas Hedberg, Chair EUnetHTA Executive Board; Chief Pharmacist, Dental and Pharmaceutical Benefits Agency, TLV
-
WHO Townhall
Session Chair:
Samvel Azatyan, Team Lead, Regulatory Convergence and Networks (RCN/REG), World Health Organization
-
Innovation, Access & Availability: Implementation of the European Medicines Agencies Network Strategy to 2025 so far
Session Chairs:
Melanie Carr, Head of Stakeholders and Communication Division, European Medicines Agency
Karl Broich, President, Federal Institute for Drugs and Medical Devices (BfArM)
-
Antimicrobial Resistance – The Ticking Time Bomb: What Progress has been made to Defuse it?
Session Chairs:
Sabine Haubenreisser, Principal Scientific Administrator, Stakeholders and Communication Division, European Medicines Agency
Inka Heikkinen, Associate Director, Global Regulatory Policy, MSD
-
Dedicated to Advancing Health Priorities: The Digital Transformation Fueling Decentralized Clinical Trials
Session Chairs:
Peter Arlett, Head Data Analytics and Methods Task Force, European Medicines Agency
Darcy Forman, ACRO Co-Chair and Chief Delivery Officer, Science 37
-
Preparing for the Next Pandemic
Session Chair:
Alan Morrison, Vice President Regulatory Affairs Intl, MSD
-
Addressing the Medicine Shortages: A Multistakeholder Overview
Session Chairs:
Marco Greco, President, European Patients' Forum
Sibilia Quilici, Executive Director, Vaccines Europe
-
Early Patient Engagement in drug development & regulatory decision making
Session Chairs:
Magda Chlebus, Executive Director, Science Policy & Regulatory Affairs, EFPIA
Marco Greco, President, European Patients' Forum
-
Precision Medicine and Regulation
Session Chair:
Bettina Ryll, Chair ESMO Patient Advocates Working Group (PAWG), Melanoma Patient Network Europe